TY - JOUR
T1 - Second-generation visually guided laser balloon ablation system for pulmonary vein isolation: Learning curve, safety and efficacy ― the MERLIN registry ―
AU - Heeger, Christian H.
AU - Phan, Huong Lan
AU - Meyer-Saraei, Roza
AU - Fink, Thomas
AU - Sciacca, Vanessa
AU - Liosis, Spyridon
AU - Brüggemann, Ben
AU - Große, Niels
AU - Fahimi, Bezhad
AU - Sano, Makoto
AU - Kuck, Karl Heinz
AU - Ouyang, Feifan
AU - Vogler, Julia
AU - Eitel, Charlotte
AU - Tilz, Roland Richard
N1 - Funding Information:
C.-H.H. received travel grants and research grants from Medtronic, Boston Scientific, Claret Medical, SentreHeart, Biosense Webster and Cardiofocus, and Speaker’s Honoraria from Biosense Webster, Cardiofocus and Boston Scientific. R.R.T. received travel grants from St. Jude Medical, Topera, Biosense Webster, Daiichi Sankyo, and SentreHeart; Speaker’s Bureau Honoraria from Biosense Webster, Biotronik, Pfizer, Topera, Bristol-Myers Squibb; Bayer, and Sano Aventis; and research grants by Cardiofocus. C.E. received travel grants and educational grants from Medtronic. K.H.K. received travel grants and research grants from Biosense Webster, Stereotaxis, Prorhythm, Medtronic, Edwards, and Cryocath, and is a consultant to St. Jude Medical, Biosense Webster, Prorhythm, and Stereotaxis. He received Speaker’s Honoraria from Medtronic. All other authors have no relevant disclosures.
Publisher Copyright:
© 2019 Japanese Circulation Society. All rights reserved.
Copyright:
Copyright 2019 Elsevier B.V., All rights reserved.
PY - 2019/11/25
Y1 - 2019/11/25
N2 - Background: Radiofrequency (RF)-based pulmonary vein isolation (PVI) results in a favorable clinical outcome, although its complexity demands a long learning curve. Balloon-based systems have been developed to possibly solve these limitations. The 2nd-generation laser balloon (LB2) offers optimized features for improved tissue contact and visibility. We determined the safety, efficacy and learning curve of the LB2 for PVI. Methods and Results: A total of 45 consecutive patients (89% persistent AF) were prospectively enrolled and divided into 3 groups (T1, T2, T3) of n=15 patients per group. All patients underwent PVI by 2 operators using the LB2. The operators were experienced in RF and cryothermal procedures, but not in laser ablations. A total of 174/177 PVs (98%) were successfully isolated. The median procedure time significantly declined from 132 (114, 158) to 119 (102, 127) and 91 (86, 105) min in T1–3, respectively (P=0.0009). Similarly, the median fluoroscopy time significantly decreased from T1 to T3 (22 (17, 27) vs. 21 (16, 24) vs. 13 (10, 17) min, respectively, P=0.045). Adverse events occurred in 6.7%, with a trend towards a lower complication rate with increasing experience. Conclusions: The LB2 was safe and effective for PVI, even for operators without any previous experience in laser balloon-based PVI. Procedure time, left atrial dwelling time and fluoroscopy time decreased after a learning curve of 15 cases.
AB - Background: Radiofrequency (RF)-based pulmonary vein isolation (PVI) results in a favorable clinical outcome, although its complexity demands a long learning curve. Balloon-based systems have been developed to possibly solve these limitations. The 2nd-generation laser balloon (LB2) offers optimized features for improved tissue contact and visibility. We determined the safety, efficacy and learning curve of the LB2 for PVI. Methods and Results: A total of 45 consecutive patients (89% persistent AF) were prospectively enrolled and divided into 3 groups (T1, T2, T3) of n=15 patients per group. All patients underwent PVI by 2 operators using the LB2. The operators were experienced in RF and cryothermal procedures, but not in laser ablations. A total of 174/177 PVs (98%) were successfully isolated. The median procedure time significantly declined from 132 (114, 158) to 119 (102, 127) and 91 (86, 105) min in T1–3, respectively (P=0.0009). Similarly, the median fluoroscopy time significantly decreased from T1 to T3 (22 (17, 27) vs. 21 (16, 24) vs. 13 (10, 17) min, respectively, P=0.045). Adverse events occurred in 6.7%, with a trend towards a lower complication rate with increasing experience. Conclusions: The LB2 was safe and effective for PVI, even for operators without any previous experience in laser balloon-based PVI. Procedure time, left atrial dwelling time and fluoroscopy time decreased after a learning curve of 15 cases.
UR - http://www.scopus.com/inward/record.url?scp=85075783700&partnerID=8YFLogxK
U2 - 10.1253/circj.CJ-19-0766
DO - 10.1253/circj.CJ-19-0766
M3 - Journal articles
C2 - 31708555
AN - SCOPUS:85075783700
SN - 1346-9843
VL - 83
SP - 2443
EP - 2451
JO - Circulation Journal
JF - Circulation Journal
IS - 12
ER -